The impact of the rs6971 polymorphism in TSPO for quantification and study design

Clinical and Translational Imaging

Volumn 3, Issue 6, 2015, Pages 417-422

  Owen, D R ^a   Guo, Q ^b   Rabiner, E A ^c,d   Gunn, R N ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ABBVIE INC   (United States)

^c Imanova Ltd   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

PET imaging; rs6971 polymorphism; TSPO

Indexed keywords

CARRIER PROTEIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; RADIOLIGAND;

AMINO ACID SUBSTITUTION; BINDING AFFINITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPING TECHNIQUE; HUMAN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 84952994214     PISSN: 22815872     EISSN: 22817565     Source Type: Journal    
DOI: 10.1007/s40336-015-0141-z     Document Type: Review

References (27)

1. Hinz R, Boellaard R (2015) Challenges of quantification of TSPO in the human brain. Clin Transl Imaging. doi:10.1007/s40336-015-0138-7
2. Imaizumi M, Briard E, Zoghbi SS, Gourley JP, Hong J, Fujimura Y et al (2008) Brain and whole-body imaging in nonhuman primates of [11C] PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage 39(3):1289–1298
3. Chauveau F, Boutin H, Van CN, Dolle F, Tavitian B (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C] PK11195 challengers. Eur J Nucl Med Mol Imagin 35(12):2304–2319
4. Brown AK, Fujita M, Fujimura Y, Liow JS, Stabin M, Ryu YH et al (2007) Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation. J Nucl Med 48(12):2072–2079
5. Fujita M, Imaizumi M, Zoghbi SS, Fujimura Y, Farris AG, Suhara T et al (2008) Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage 40(1):43–52
6. Ikoma Y, Yasuno F, Ito H, Suhara T, Ota M, Toyama H et al (2007) Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C] DAA1106. J Cereb Blood Flow Metab 27(1):173–184
7. Fujimura Y, Zoghbi SS, Simeon FG, Taku A, Pike VW, Innis RB et al (2009) Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06. J Nucl Med 50(7):1047–1053
8. Owen DR, Howell OW, Tang SP, Wells LA, Bennacef I, Bergstrom M et al (2010) Two binding sites for [3H] PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab 30(9):1608–1618
9. Guo Q, Owen DR, Rabiner EA, Turkheimer FE, Gunn RN (2012) Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo. NeuroImage 60(2):902–910
10. Owen DR, Gunn RN, Rabiner EA, Bennacef I, Fujita M, Kreisl WC et al (2011) Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med 52(1):24–32
11. Owen DR, Lewis AJ, Reynolds R, Rupprecht R, Eser D, Wilkins MR et al (2011) Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain. Synapse (NY) 65(3):257–259
12. Guo Q, Colasanti A, Owen DR, Onega M, Kamalakaran A, Bennacef I et al (2013) Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding. J Nucl Med 54(11):1915–1923
13. Mizrahi R, Rusjan PM, Kennedy J, Pollock B, Mulsant B, Suridjan I et al (2012) Translocator protein (18 kDa) polymorphism (rs6971) explains in vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA. J Cereb Blood Flow Metab 32(6):968–972
14. Lavisse S, Garcia-Lorenzo D, Peyronneau MA, Bodini B, Thiriez C, Kuhnast B et al (2015) Optimized quantification of translocator protein radioligand 18F-DPA-714 uptake in the brain of genotyped healthy volunteers. J Nucl Med 56(7):1048–1054
15. Yoder KK, Nho K, Risacher SL, Kim S, Shen L, Saykin AJ (2013) Influence of TSPO genotype on 11C-PBR28 standardized uptake values. J Nucl Med 54:1320–1322
16. Kreisl WC, Jenko KJ, Hines CS, Lyoo CH, Corona W, Morse CL et al (2013) A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab 33(1):53–58
17. Kobayashi M, Jenko K, Zoghbi S, Lohith T, Rallis-Frutos D, Page E, Ikawa M, Pike V, Innis R, Fujita M (2015) Blockade of translocator protein (TSPO) to measure specific binding of 11C-(R)-PK 11195 in human brain. J Nucl Med 56:467
18. Owen DR, Guo Q, Kalk NJ, Colasanti A, Kalogiannopoulou D, Dimber R et al (2014) Determination of [(11)C] PBR28 binding potential in vivo: a first human TSPO blocking study. J Cereb Blood flow Metab 34(6):989–994
19. Jucaite A, Cselenyi Z, Arvidsson A, Ahlberg G, Julin P, Varnas K et al (2012) Kinetic analysis and test-retest variability of the radioligand [11C] (R)-PK11195 binding to TSPO in the human brain—a PET study in control subjects. EJNMMI Res 2:15
20. Park E, Gallezot JD, Delgadillo A, Liu S, Planeta B, Lin SF et al (2015) (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas. Eur J Nucl Med Mol Imagin 42(7):1081–1092
21. Salinas CA, Searle GE, Gunn RN (2015) The simplified reference tissue model: model assumption violations and their impact on binding potential. J Cereb Blood Flow Metab 35(2):304–311
22. Canat X, Carayon P, Bouaboula M, Cahard D, Shire D, Roque C et al (1993) Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci 52(1):107–118
23. Rizzo G, Veronese M, Tonietto M, Zanotti-Fregonara P, Turkheimer FE, Bertoldo A (2014) Kinetic modeling without accounting for the vascular component impairs the quantification of [(11)C] PBR28 brain PET data. J Cereb Blood Flow Metab 34(6):1060–1069
24. Fan Z, Harold D, Pasqualetti G, Williams J, Brooks DJ, Edison P (2015) Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort? J Nucl Med 56(5):707–713
25. Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW et al (2015) Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med 56(5):701–706
26. Hannestad J, Gallezot JD, Schafbauer T, Lim K, Kloczynski T, Morris ED et al (2012) Endotoxin-induced systemic inflammation activates microglia: [11C] PBR28 positron emission tomography in nonhuman primates. NeuroImage 63(1):232–239
27. Yoder KK, Territo PR, Hutchins GD, Hannestad J, Morris ED, Gallezot JD et al (2015) Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C] PBR28 brain uptake. Nucl Med Biol 42(3):305–308